reference/8485198

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8485198

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase I\|Journal Article\|Randomized Controlled Trial\|Research Support, U.S. Gov't, P.H.S.
endingPage	1154
issn	0269-9370
issueIdentifier	8
pageRange	1147-1154
publicationName	AIDS (London, England)
startingPage	1147
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_266f09c09d1e3aa97cbfe9240f44f32b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_291a28ce978529143a5be1d9f03e443c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_61f24a3b7e1e33a320cd250667eaad91 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8bf6fab62dfea1938e20f1e4cefb5dc6 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b1adbc1a2de3b36895a086c2f0b4103a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_996a952cd9be7849647df8458d92f314
bibliographicCitation	Jacobson MA, Spritzler J, Landay A, Chan E, Katzenstein D, Schock B, Fox L, Roe J, Kundu S, Pollard R; AACTG 325 Protocol Team. A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection. AIDS. 2002 May 24;16(8):1147–54. doi: 10.1097/00002030-200205240-00008. PMID: 12004273.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6807228842cbef21f8153df43c7d6b1d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b4eff03d483769fe97a1e3510e3c6f22 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb78a6b291b69a63cf4421485887421f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8593-4560 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2bd30ca6d986b363e38199e3d921f394 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_932e97e667dd0f574c3eb2202456e473 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32fd4d6fd9057ff4aca296361104a3b3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ba30129c410c60f3d8601855924c2a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54d7f2c9b1d5b0c95506f61da5f44e5c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_047763307d49a53b124a6ff63a7c3db7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4899f9d36ff70e2c56ec3bdd2c56ba7f
date	2002-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/12004273 https://doi.org/10.1097/00002030-200205240-00008
isPartOf	https://portal.issn.org/resource/ISSN/0269-9370 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1493
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection
discusses	http://id.nlm.nih.gov/mesh/M0011490 http://id.nlm.nih.gov/mesh/M0029376 http://id.nlm.nih.gov/mesh/M0027969 http://id.nlm.nih.gov/mesh/M0018641 http://id.nlm.nih.gov/mesh/M0028839
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D018664Q000627 http://id.nlm.nih.gov/mesh/D015658Q000188 http://id.nlm.nih.gov/mesh/D019380Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D019380Q000009 http://id.nlm.nih.gov/mesh/D018664Q000009 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D011994Q000627 http://id.nlm.nih.gov/mesh/D007958 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008214Q000276 http://id.nlm.nih.gov/mesh/D011994Q000009 http://id.nlm.nih.gov/mesh/D019798Q000097 http://id.nlm.nih.gov/mesh/D007371Q000097 http://id.nlm.nih.gov/mesh/D002455
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9688 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9391 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_58cdf0fdfee46355623cd3b8ccaf2e9a http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_518fd46dddb3f97e176198f08ec766d6 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398721 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2995a6fdb6776aa7a783d6f332892f3d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4d8d2b25153fa9ba1feb2f14997dac4f http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9765 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2775c2458e9fa68b2acf66fcef465125 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c37c4e80515b927da0969aacdb9547a9

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127537750

Total number of triples: 70.